Cytokinetics Inc (CYTK)
55.83
-0.12
(-0.21%)
USD |
NASDAQ |
Nov 14, 11:11
Cytokinetics Revenue (Annual): 7.53M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.53M |
| December 31, 2022 | 94.59M |
| December 31, 2021 | 70.43M |
| December 31, 2020 | 55.83M |
| December 31, 2019 | 26.87M |
| December 31, 2018 | 31.50M |
| December 31, 2017 | 13.37M |
| December 31, 2016 | 106.41M |
| December 31, 2015 | 28.66M |
| December 31, 2014 | 46.94M |
| December 31, 2013 | 30.65M |
| December 31, 2012 | 7.559M |
| Date | Value |
|---|---|
| December 31, 2011 | 4.00M |
| December 31, 2010 | 2.577M |
| December 31, 2009 | 81.54M |
| December 31, 2008 | 12.42M |
| December 31, 2007 | 13.62M |
| December 31, 2006 | 3.127M |
| December 31, 2005 | 8.912M |
| December 31, 2004 | 13.44M |
| December 31, 2003 | 10.58M |
| December 31, 2002 | 11.40M |
| December 31, 2001 | 8.466M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
7.53M
Minimum
2023
94.59M
Maximum
2022
51.05M
Average
55.83M
Median
2020
Revenue (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.828B |
| Biomarin Pharmaceutical Inc | 2.419B |
| Catalyst Pharmaceuticals Inc | 398.20M |
| Sarepta Therapeutics Inc | 1.243B |
| Ocugen Inc | 6.036M |